Post-menopausal women are at a higher risk of develo** Alzheimer's disease (AD) than
males. The higher rates of AD in women are associated with the sharp decline in the …

Neurodegenerative diseases are one of the leading causes of disability and death
worldwide. Intracellular transduction pathways that end in the activation of specific …

Background Inflammation contributes to the poor prognosis of intracerebral hemorrhage
(ICH). Intermittent fasting (IF) has been shown to be protective against inflammation in …

Perimenopausal depression, occurring shortly before or after menopause, is characterized
by symptoms such as emotional depression, anxiety, and stress, often accompanied by …

Glutamatergic dysfunction has been implicated in the pathophysiology of multiple conditions
including epilepsy, chronic pain, post-traumatic stress disorder (PTSD), and premenstrual …

Disruptions in brain energy metabolism, oxidative damage, and neuroinflammation are
commonly seen in traumatic brain injury (TBI). Microglial activation is the hallmark of …

In females, Alzheimer's disease (AD) incidences increases as compared to males due to
estrogen deficiency after menopause. Estrogen therapy is the mainstay therapy for …

Intermittent fasting (IF) is an ecological strategy to control various metabolic disorder
symptoms, but its protective effect on type 1 diabetes (T1D)-induced cognitive dysfunction …

In order to promote gastrointestinal health, significant increases in the prevalence of
gastrointestinal disorders should be paralleled by similar surges in therapeutics research …

Epilepsy, characterized by recurrent seizures, poses a significant health challenge globally.
Despite the availability of anti-seizure medications, their adverse effects and inadequate …